news.sunovion.comSumitomo Pharma America Newsroom - News Releases
news.sunovion.com Profile
News.sunovion.com is a subdomain of sunovion.com, which was created on 2009-09-07,making it 15 years ago.
Discover news.sunovion.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
news.sunovion.com Information
| HomePage size: 72.293 KB |
| Page Load Time: 0.45612 Seconds |
| Website IP Address: 162.159.129.11 |
news.sunovion.com Similar Website
| Harbor Freight Newsroom - Press Releases & Corporate News |
| Sumitomo Gearmotors, Gearboxes & Speed Reducers | The Gearbox You Deserve |
| Primary Arms News & Press Releases - Primary Arms News & Press Releases |
| Ascension Press Newsroom - Press Releases for Ascension |
| Top Pharma conference 2022 | Asia Pharma Conferences 2022 | Asia Pharma 2022 | Pharma Congress 2022 |
| Fender Press Releases & Products Updates | Fender Newsroom |
| Recent News Releases & Coverage | Progressive Newsroom |
| big pharma news headlines - big pharma News |
| Pharma Industry News - Pharma Industry News |
| Bank of America Newsroom for the Latest Press Releases |
| All News Releases and Press Releases from PRWeb |
| Global Press Releases - News, articles and press releases. |
| Newsroom — press releases and news articles for Amway Global |
| Media newsroom – Here you will find all press releases, publications and key press |
| Newsroom and Media Resources | WDAY Press Releases | |
news.sunovion.com PopUrls
| Sunovion Pharmaceuticals Inc. - Press Releases https://news.sunovion.com/press-releases/ |
| Sunovion Pharmaceuticals Inc. - Page Not Found https://news.sunovion.com/PageNotFound/default.aspx |
| Sunovion Pharmaceuticals Inc. - Email Alerts https://news.sunovion.com/email-alerts/default.aspx |
| About Sunovion Pharmaceuticals Inc. https://news.sunovion.com/files/doc_multimedia/3043501cSunovion_Pharmaceuticals_Inc.pdf |
| Sumitomo Pharma America Newsroom - News Releases https://news.sunovion.com/featured-news-overview/default.aspx |
| Sunovion Discontinues Dasotraline Program https://news.sunovion.com/press-releases/press-releases-details/2020/Sunovion-Discontinues-Dasotraline-Program/default.aspx |
| Sunovion Pharmaceuticals to Acquire Cynapsus ... https://news.sunovion.com/press-releases/press-releases-details/2016/Sunovion-Pharmaceuticals-to-Acquire-Cynapsus-Therapeutics/default.aspx |
| Sunovion Celebrates Five-Year Anniversary Milestone https://news.sunovion.com/press-releases/press-releases-details/2015/Sunovion-Celebrates-Five-Year-Anniversary-Milestone/default.aspx |
| Sunovion Pharmaceuticals Completes Acquisition of ... https://news.sunovion.com/press-releases/press-releases-details/2016/Sunovion-Pharmaceuticals-Completes-Acquisition-of-Cynapsus-Therapeutics/default.a |
news.sunovion.com Httpheader
| Date: Tue, 14 May 2024 20:14:17 GMT |
| Content-Type: text/html; charset=UTF-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| X-Frame-Options: SAMEORIGIN |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Cache-Control: public, no-cache |
| Vary: Accept-Encoding |
| CF-Cache-Status: EXPIRED |
| Last-Modified: Tue, 14 May 2024 18:17:00 GMT |
| Set-Cookie: __cf_bm=bn7Rt3QjZr5l3tNWuQD2zKi2yl2y7yKLYHdIHn3t2pU-1715717657-1.0.1.1-JwFXeN_teeXakhBkipL7CTJcudEDk_4Bp.2fRRo3JiZmswXqY75J8V1yD_SLzXp3BjO4V6y24ID.u6Fo6ivzUw; path=/; expires=Tue, 14-May-24 20:44:17 GMT; domain=.news.us.sumitomo-pharma.com; HttpOnly; Secure; SameSite=None, __cfruid=3a3443a4e4fa00ac6c193acbcf48ed70c58d1577-1715717657; path=/; domain=.news.us.sumitomo-pharma.com; HttpOnly; Secure; SameSite=None |
| Server: cloudflare |
| CF-RAY: 883d8dbd28667aaf-SJC |
news.sunovion.com Meta Info
| content="IE=edge" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport"/ |
| content="" name="keywords" |
| content="" name="description" |
| content="summary" name="twitter:card"/ |
| content="Sumitomo Pharma America Newsroom" property="og:site_name"/ |
| content="https://news.us.sumitomo-pharma.com/index.php?s=20295" property="og:url"/ |
news.sunovion.com Html To Plain Text
Newsroom Join Us Contact UsSMPA Leadership Affiliates Science Focus Areas Pipeline Clinical Trials Products Technology Our ImpactMedia Contact: Kirsten Fallon CorpComms@us.sumitomo-pharma.com News Releases Stay up to date with SMPA The latest company news, press releases, and resources about Sumitomo Pharma America, our employees, our partners, and our latest innovations. Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Get News Alerts by Email Year All Years 2024 2023 2022 2021 2020 Keywords Go Advanced Search Search Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Basic Search May 13, 2024 Sumitomo Pharma Announces FDA Acceptance of Supplemental New Drug Application for Vibegron in Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia –Supplemental New Drug Application (sNDA) submission based on Phase 3 study of vibegron 75mg (GEMTESA) demonstrating statistically significant reductions in daily micturition and urgency episodes– May 7, 2024 Sumitomo Pharma Presents Urology and Oncology Data at AUA 2024 Annual Meeting –Data includes results from Phase 3 study of vibegron 75mg (GEMTESA) in men living with overactive bladder receiving pharmacological treatment for benign prostatic hyperplasia– MARLBOROUGH, Mass., Mar 15, 2024 Sumitomo Pharma Enters into an Agreement to Amend the Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds Including Ulotaront with Otsuka Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President, and CEO: Hiroshi Nomura; Securities Code: 4506, Prime Market of TSE) and its U.S.-based subsidiary... Mar 12, 2024 Sumitomo Pharma Announces Availability of ORGOVYX® (relugolix) in Canada, the First and Only Oral Androgen Deprivation Therapy Treatment for Men with Advanced Prostate Cancer Sumitomo Pharma Canada, Inc., announced today that ORGOVYX® (relugolix), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, is now available for prescription in Canada for the... Jan 31, 2024 Sumitomo Pharma and Pfizer Canada Announce Availability of MYFEMBREE® in Canada In partnership with Sumitomo Pharma Canada, Inc., Pfizer Canada ULC is proud to announce that supply of MYFEMBREE® (relugolix 40 mg, estradiol 1 mg and norethindrone acetate tablets 0.5 mg... Show 5 10 25 50 100 per page « 1 2 3 4 5 6 7 8 9 » Open a printable version of this page Email the URL of this page to a friend Get the RSS feed for this page Share this page on Twitter Share this page on LinkedIn Share this page on FacebookScience Products Technology Our Impact Newsroom Join Us Contact Us LinkedIn LinkedIn Privacy Notice Terms Of Use Medical Disclaimer Social Media Community Guidelines Accessibility Statement Corporate Transparency Documents ©2024 Sumitomo Pharma America, Inc. All rights...
news.sunovion.com Whois
Domain Name: SUNOVION.COM Registry Domain ID: 1568231993_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2023-08-28T02:54:41Z Creation Date: 2009-09-07T04:49:38Z Registry Expiry Date: 2024-09-07T04:49:38Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1516.AWSDNS-61.ORG Name Server: NS-1952.AWSDNS-52.CO.UK Name Server: NS-251.AWSDNS-31.COM Name Server: NS-738.AWSDNS-28.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T21:10:19Z <<<